Meyka Pro banner
JMS Co.,Ltd.

JMS Co.,Ltd. Fundamental Analysis (JPX: 7702.T)

7702.TJPX
HealthcareMedical - Instruments & Supplies
¥462.00
¥1.00(0.22%)
Japanese Market opens in 0h 33m

JMS Co.,Ltd. Fundamental Analysis (JPX: 7702.T)

JMS Co.,Ltd. (JPX: 7702.T) shows weak financial fundamentals with a PE ratio of -16.12, profit margin of -1.08%, and ROE of -1.70%. The company generates $65.4B in annual revenue with weak year-over-year growth of -5.60%.

Key Strengths

Cash Position77.44%
PEG Ratio-0.03
Current Ratio1.79

Areas of Concern

ROE-1.70%
Operating Margin0.67%
We analyze 7702.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 14.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
14.6/100

We analyze 7702.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

7702.T struggles to generate sufficient returns from assets.

ROA > 10%
-0.85%

Valuation Score

Excellent

7702.T trades at attractive valuation levels.

PE < 25
-16.12
PEG Ratio < 2
-0.03

Growth Score

Weak

7702.T faces weak or negative growth trends.

Revenue Growth > 5%
-5.60%
EPS Growth > 10%
-9.80%

Financial Health Score

Excellent

7702.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.63
Current Ratio > 1
1.79

Profitability Score

Weak

7702.T struggles to sustain strong margins.

ROE > 15%
-169.79%
Net Margin ≥ 15%
-1.08%
Positive Free Cash Flow
No

Key Financial Metrics

Is 7702.T Expensive or Cheap?

P/E Ratio

7702.T trades at -16.12 times earnings. This suggests potential undervaluation.

-16.12

PEG Ratio

When adjusting for growth, 7702.T's PEG of -0.03 indicates potential undervaluation.

-0.03

Price to Book

The market values JMS Co.,Ltd. at 0.27 times its book value. This may indicate undervaluation.

0.27

EV/EBITDA

Enterprise value stands at -1.30 times EBITDA. This is generally considered low.

-1.30

How Well Does 7702.T Make Money?

Net Profit Margin

For every $100 in sales, JMS Co.,Ltd. keeps $-1.08 as profit after all expenses.

-1.08%

Operating Margin

Core operations generate 0.67 in profit for every $100 in revenue, before interest and taxes.

0.67%

ROE

Management delivers $-1.70 in profit for every $100 of shareholder equity.

-1.70%

ROA

JMS Co.,Ltd. generates $-0.85 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.85%

Following the Money - Real Cash Generation

Operating Cash Flow

JMS Co.,Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

JMS Co.,Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

7702.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-16.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.27

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.17

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.63

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.79

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.008

vs 25 benchmark

How 7702.T Stacks Against Its Sector Peers

Metric7702.T ValueSector AveragePerformance
P/E Ratio-16.1232.13 Better (Cheaper)
ROE-1.70%552.00% Weak
Net Margin-1.08%30215.00% Weak
Debt/Equity0.630.56 Neutral
Current Ratio1.795.70 Neutral
ROA-0.85%8.00% Weak

7702.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews JMS Co.,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

13.83%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-144.95%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-57.83%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ